ENT Devices Market Research Report Information By Product (Diagnostic Devices (Endoscopes (Rigid Endoscopes, Otoscopes, and Sinuscopes), Flexible Endoscopes (Rhinoscopes, Laryngoscopes, Pharyngoscopes, and Nasopharyngoscopes), Hearing Screening Devices), Surgical Devices (Powered Surgical Instruments, Radiofrequency (RF) Handpieces, and Handheld Instruments, (Rhinology Instruments, Otology Instruments, Laryngeal Instruments, Head And Neck Surgery Instruments, and Others), Balloon Sinus Dilation Devices, ENT Supplies (Packing Material and Na

Global ENT Devices Market Overview

The ENT Devices Market Size was valued at USD 19.4 billion in 2022 and is projected to grow from USD 20.60 Billion in 2023 to USD 29.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.41% during the forecast period (2023 - 2030). The growing prevalence of geriatric populations and rising incidences of ENT disorders are just a few of the market drivers that are driving the market.Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

ENT Devices Market Trends

• Growing prevalence of ENT disorders to boost market growth

Untreated hearing loss is an urgent public health issue that demands urgent attention from policymakers, healthcare providers, and civil society worldwide. According to the World Health Organization's (WHO) World Report on Hearing, nearly 2.5 billion people worldwide, or 1 in 4 people, will have some hearing loss by 2050. If nothing is done, at least 700 million people will need access to ear and hearing care and other rehabilitation services. The report, released in advance of World Hearing Day on 3rd March, highlights the need to swiftly intensify efforts to prevent and address hearing loss by investing in and enhancing access to ear and hearing care services. Additionally, the prevalence of disabling hearing loss differs significantly between nations with various income levels. With 3.3% of the population affected, low-income countries have the lowest unadjusted crude prevalence, whereas high-income countries have the highest prevalence, reaching 7.5%. Since high-income nations typically have older populations more likely to experience age-related hearing loss, this discrepancy can be attributed primarily to the demographic profiles of the two countries. Thus, such growing initiatives are creating awareness among the population this factor is driving the market CAGR.

Figure 1: Prevalence of moderate of higher level of hearing loss in different age groupsSource: Secondary Research, Primary Research, MRFR Database, and Analyst Review

The world's geriatric population continues to grow at an unprecedented rate. According to the World Health Organization, 1 in six people will be 60 or older by 2030. There will be 1.4 billion people over 60, up from 1 billion in 2020. The number of people who are 60 years or older worldwide will double by 2050. (2.1 billion). Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million. The aging population is highly susceptible to various disorders. There is a growing understanding of the numerous issues in geriatric otolaryngology caused by multiple degenerative changes in the head and neck area. Due to the high prevalence of head and neck cancer in old age, the affliction of the special senses of hearing and olfaction shortens life expectancy and lowers the quality of life. Thus, it is anticipated that this aspect will accelerate ENT Devices market revenue globally.

Moreover, the development of medical science has been greatly influenced by technological advancements. These advancements have significantly impacted otolaryngologists' (ENT specialists') ability to treat cancer patients and the deaf and hard of hearing and carry out challenging surgeries.

ENT Devices Market Segment Insights

ENT Devices Product Insights

The Market segments of ENT Devices, based on Product, includes diagnostic, surgical, hearing aids, hearing implants, Co2 lasers, and image-guided surgery systems. The diagnostic segment is further categorized into endoscopes, flexible endoscopes, and hearing screening devices. The surgical segment is further categorized into powered surgical instruments, radiofrequency (RF) handpieces, handheld instruments, balloon sinus dilation devices, ENT supplies, ear tubes, and voice prosthesis devices. The surgical ENT devices segment held the majority share in 2022 in the ENT Devices Market data. The growing preference for minimally invasive procedures and the prevalence of ENT disorders are driving the segment's growth. Moreover, the segment is also driven by technological advancements, new product launches, and mergers and acquisitions. The hearing implants segment is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the growing use of hearing implants, growing knowledge of cochlear implants as non-invasive procedures, and the introduction of new products by major companies.

ENT Devices End Users Insights

The ENT Devices Market data, based on end users, includes hospitals, ambulatory settings, ENT clinics, research, and academic institutes, home care settings, and others. The hospital’s segment dominated the ENT Devices market revenue in 2022. Adoption of technologically advanced ENT devices, high prevalence of ENT conditions, including sinusitis and hearing loss, and increased efforts to improve access to healthcare facilities to spur market growth. Additionally, the market is expanding due to increased purchasing power and the availability of highly qualified hearing care professionals.

Figure 2: ENT Devices Market, by End user, 2022 & 2030 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

ENT Devices Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America ENT Devices market accounted for USD 8.9 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The market of ENT devices is expanding significantly in this region due to factors including the rising geriatric population, rising ENT-related disorder prevalence, rising public awareness of these disorders, and rising adoption of minimally invasive ENT devices. Additionally, the market of ENT devices in North America is expanding due to an increase in product development and launch activities as well as a significant demand for cosmetic ENT treatments.

Further, the major countries studied in the market report are: The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: ENT DEVICES MARKET SHARE BY REGION 2022 (%)Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe ENT Devices market accounts for the second-largest market share. Increased health awareness, rising healthcare costs, and the rapidly rising acceptance of minimally invasive surgeries are a few of the key drivers of ENT device demand in the European region. Additionally, the adoption of emerging technologies like AI and ML as well as innovations in auditory products are boosting the industry's growth. Moreover, the UK market of ENT Devices held the largest market share, and the Germany market of ENT Devices was the fastest-growing market in the region.

Asia Pacific ENT Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. It is anticipated that technological developments like wireless, real-time monitoring devices, rising healthcare spending, and support from regulatory bodies will foster the market growth in the Asia Pacific region. Moreover, the rising geriatric population coupled with the growing prevalence of ENT are key factors aiding the growth in this region. Further, the China market of ENT Devices held the largest market share, and the India market of ENT Devices was the fastest-growing market in the region.

ENT Devices Key Market Players & Competitive Insights

Major market players are investing in the R&D of various products such that they are advanced and low-cost. Market participants frequently use inorganic strategic alliances, such as partnerships, acquisitions, and capacity expansions, in addition to investments, to strengthen their market positions and gain competitive advantages. Competitors in the ENT Devices industry must offer cost-effective items to survive in an increasingly competitive environment.

One of the key strategies adopted by manufacturers in the market of ENT Devices is launching new products in the market. In recent years, the industry has been collaborating with other companies in the market. The ENT Devices market major player such as Atos Medical AB, Cochlear Limited, Hoya Corporation, Johnson & Johnson Services Inc., Karl Storz Gmbh & Co. Kg, Medtronic PLC, Olympus Corporation, Rion Co. Ltd, and Siemens Healthcare is working on the development of new products.

Siemens Healthineers offers of products, services, and solutions the center of clinical decision-making and treatment pathways. The company develops patient-centered products. Siemens Healthineers In April 2021, Varian and Siemens Healthineers are expanding on their long-standing strategic alliance known as "EnVision" to create a comprehensive digital, diagnostic, and therapeutic ecosystem that includes treatment management.

Cochlear is a pioneer in implantable hearing aids that aid in hearing restoration and introduce users to a world of sound. In April 2022, Cochlear Ltd., a leader in the production of hearing aids on a global scale, should establish a manufacturing base in India, according to Commerce and Industry Minister Piyush Goyal, as doing so would give the company access to a sizable domestic market in addition to opportunities for exports to other nations.

Key Companies in the market of ENT Devices include

• Atos Medical AB


• Cochlear Limited


• Hoya Corporation


• Johnson & Johnson Services Inc.


• Karl Storz Gmbh & Co. Kg


• Medtronic PLC


• Olympus Corporation


• Rion Co. Ltd


• Siemens Healthcare, among others

ENT Devices Industry Developments

November 2023Medtronic's NuVent Eustachian tube dilation balloon receives FDA approval for the treatment of chronic obstructive Eustachian tube dysfunction (CETD). CETD is a condition that prevents the Eustachian tubes from functioning properly, leading to ear pain, pressure, and fullness. The NuVent balloon is designed to open up the Eustachian tubes and restore normal hearing.Acclarent, a Johnson & Johnson company, announces the launch of its first-ever AI-powered ENT technology. The technology is designed to simplify surgical planning and provide real-time feedback during ENT navigation procedures.Stryker Corporation launches its new ReSurgeon robotic-assisted ENT surgery system. The ReSurgeon system is designed to provide surgeons with greater precision and control during ENT procedures.October 2023:KARL STORZ GmbH & Co. KG and Google Cloud announce a partnership to develop new AI-powered ENT solutions. The partnership will combine KARL STORZ's expertise in ENT devices with Google Cloud's expertise in AI to develop new solutions that can improve patient care and outcomes.Smith & Nephew plc announces the launch of its new NAVISENT ENT navigation system. The NAVISENT system is designed to provide surgeons with real-time 3D visualization of the patient's anatomy during ENT procedures.William Demant Holding A/S announces the acquisition of Medtronic's hearing loss business for $9.1 billion. The acquisition will make William Demant the world's largest hearing aid manufacturer.

ENT Devices Market Segmentation

ENT Devices Product Outlook (USD Billion, 2018-2030)

• 
  Diagnostic Devices
  
  
  
  • 
    Endoscopes
    
    
    
    • 
      Rigid Endoscopes
      
      
      
      • Otoscopes
      
      
      • Sinuscopes
      
      
      
      
    
    
    • 
      Flexible Endoscopes
      
      
      
      • Rhinoscopes
      
      
      • Laryngoscopes
      
      
      • Pharyngoscopes
      
      
      • Nasopharyngoscopes
      
      
      
      
    
    
    • Hearing Screening Devices
    
    
    
    
  
  
  • 
    Surgical Devices
    
    
    
    • Powered Surgical Instruments
    
    
    • Radiofrequency (RF) Handpieces
    
    
    • 
      Handheld Instruments
      
      
      
      • Rhinology Instruments
      
      
      • Otology Instruments
      
      
      • Laryngeal Instruments
      
      
      • Head And Neck Surgery Instruments
      
      
      • Others
      
      
      
      
    
    
    • Balloon Sinus Dilation Devices
    
    
    • 
      ENT Supplies
      
      
      
      • Packing Material
      
      
      • Nasal Stents & Splints
      
      
      
      
    
    
    • Ear Tubes
    
    
    • Voice Prosthesis Devices
    
    
    
    
  
  
  • Hearing Aids
  
  
  • Hearing Implants
  
  
  • Co2 Lasers
  
  
  
  

• Image-Guided Surgery Systems

ENT Devices End-User Outlook (USD Billion, 2018-2030)

• Hospitals


• Ambulatory Settings


• ENT Clinics


• Research And Academic Institutes


• Home Care Settings

• Others

ENT Devices Regional Outlook (USD Billion, 2018-2030)

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America